High-Grade Urothelial Carcinoma (HGUC)

  • Chapter
  • First Online:
The Paris System for Reporting Urinary Cytology

Abstract

High-grade urothelial carcinoma (HGUC) is diagnosed using major criteria which include high N/C ratio, irregular nuclear membranes, and coarse chromatin. TPS second edition recognizes these criteria to be stringent in order to normalize the cytomorphologic heterogeneity of HGUC on urine samples and has included notable variances which may be present in urine samples. These variances are most notably N/C ratios that have a wide range in tumor cells and hypochromasia in select cases, along with HGUC sub-types, all of which impact cytologic interpretation. Degeneration of tumor cells also affects diagnosis of HGUC. The recognition of the major criteria and the variances will help in diagnosis of HGUC on cytologic specimens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Spain)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 50.28
Price includes VAT (Spain)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 62.39
Price includes VAT (Spain)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Siddiqui MT, Fadda G, Han JH, Owens CL, Tabatabai ZL, Tsuzuki T. High Grade Urothelial Carcinoma (HGUC). In: Rosenthal DL, Wojcik EM, Kurtycz DFI, editors. The Paris system for reporting urinary cytology. Springer; 2016. p. 61–74.

    Chapter  Google Scholar 

  2. Koh HH, Lee MJ, Park NJ, Kim H-S, Oh YL. Impact of implementing the Paris system for reporting urinary cytology: a single-institutional experience with emphasis on diagnostic yield of high-grade urothelial carcinoma and low-grade urothelial neoplasm. Anticancer Res. 2020;40(6):3477–84.

    Article  Google Scholar 

  3. Danakas A, Sweeney M, Cheris S, Agrawal T. Urinary tract cytology: a cytologic-histopathologic correlation with the Paris system, an institutional study. J Am Soc Cytopathol. 2021;10(1):56–63.

    Article  Google Scholar 

  4. Anbardar MH, Monjazeb R. Reclassification of urinary cytology regarding the Paris system for reporting urinary cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma. Diagn Cytopathol. 2020;48(5):446–52.

    Article  Google Scholar 

  5. Cowan ML, VandenBussche CJ. The Paris system for reporting urinary cytology: early review of the literature reveals successes and rare shortcomings. J Am Soc Cytopathol. 2018;7:185–94.

    Article  Google Scholar 

  6. Kurtycz DFI, Sundling KE, Barkan GA. The Paris system for reporting urinary cytology: strengths and opportunities. Diagn Cytopathol. 2020;48:890–5.

    PubMed  Google Scholar 

  7. Pastorello RG, Barkan GA, Saieg M. Experience on the use of the Paris system for reporting urinary cytopathology: review of the published literature. J Am Soc Cytopathol. 2021;10(1):79–87.

    Article  Google Scholar 

  8. Meilleroux J, Daniel G, Aziza J, Md’Aure D, Quintyn-Ranty ML, Basset CMI, Evrad SM, Courtade-Saidi MM. One year of experience using the Paris system for reporting urinary cytology. Cancer Cytopathol. 2018;126:430–6.

    Article  Google Scholar 

  9. Stanzione N, Ahmed T, Fung PC, Cai D, Lu DY, Sumida LC, Moatamed NA. The continual impact of the Paris system on urine cytology, a 3-year experience. Cytopathology. 2020;31:35–40.

    Article  Google Scholar 

  10. De Paula R, Oliveira A, Nunes W, Bovolim G, Domingos T, Brot LD, Bezerra S, Cunha I, Morini M, Saieg M. Two-year study on the application of the Paris system for urinary cytology in a cancer center. Cytopathology. 2020;31:41–6.

    Article  Google Scholar 

  11. Cowan ML, Rosenthal DL, VandenBussche CJ. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris system for reporting urinary cytology. Cancer Cytopathol. 2017;125:427–34.

    Article  CAS  Google Scholar 

  12. Pierconti F, Martini M, Straccia P, Fiorentino V, Musarra T, Larocca LM, Lopez-Beltran A. Hypochromatic large urothelial cells in urine cytology are indicative of high-grade urothelial carcinoma. APMIS. 2018;126:705–9.

    Article  CAS  Google Scholar 

  13. Renshaw AA, Gould EW. High-grade urothelial carcinoma with hypochromatic chromatin in urine cytology. J Am Soc Cytopathol. 2021;10:25–8.

    Article  Google Scholar 

  14. Renshaw AA, Gould EW. High-grade urothelial carcinoma on urine cytology resembling umbrella cells. Acta Cytol. 2018;62:62–7.

    Article  Google Scholar 

  15. Renshaw AA, Gould EW. High-grade urothelial carcinoma in urine cytology with jet black and smooth or glassy chromatin. Cancer Cytopathol. 2018;126:64–8.

    Article  CAS  Google Scholar 

  16. Vaickus LJ, Tambouret RH. Young investigator challenge: the accuracy of the nuclear-to-cytoplasmic ratio estimation among trained morphologists. Cancer Cytopathol. 2015;123(9):524–30.

    Article  Google Scholar 

  17. Layfield LJ, Esebua M, Frazier SR, Hammer RD, Bivin WW, Nguyen V, Ersoy I, Schmidt RL. Accuracy and reproducibility of nuclear/cytoplasmic ratio assessments in urinary cytology specimens. Diagn Cytopathol. 2017;45(2):107–12.

    Article  Google Scholar 

  18. Zhang ML, Guo AX, VandenBussche CJ. Morphologists overestimate the nuclear-to-cytoplasmic ratio. Cancer Cytopathol. 2016;124(9):669–77.

    Article  CAS  Google Scholar 

  19. McIntire PJ, Snow JT, Elsoukkary SS, Soong L, Sweeney J, Robinson BD, Siddiqui MT. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens. Cancer Cytopathol. 2019;127(2):120–4.

    Article  CAS  Google Scholar 

  20. Allison DB, Olson MT, Lilo M, Zhang ML, Rosenthal DL, VandenBussche CJ. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens? Cancer Cytopathol. 2016;124(6):436–42.

    Article  Google Scholar 

  21. Suh J, Go H, Sung C, et al. Modification of the Paris system for urinary tract washing specimens using diagnostic cytological features. Cytopathology. 2017;28(6):516–23.

    Article  CAS  Google Scholar 

  22. Moch H. International Agency for Research on C. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. Lyon: International Agency for Research on Cancer; 2016.

    Google Scholar 

  23. Yoo Y, Choi E, Lee DH, Park S, Sung SH. Diagnostic value of urine cytology in detecting histologic variants of urothelial carcinoma in the urinary bladder: Cytopathologic correlation of 72 cases. Diagn Cytopathol. 2021;49(3):367–73.

    Article  Google Scholar 

  24. Cardillo M, Reuter VE, Lin O. Cytologic features of the nested variant of urothelial carcinoma. Cancer Cytopathol. 2003;99(1):23–7.

    Article  Google Scholar 

  25. Suo L, Vega I, Thrall M. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in the Paris system for reporting urine cytology ? J Am Soc Cytopathol. 2021;10:20–4.

    Article  Google Scholar 

  26. Straccia P, Martini M, Sacco E, Bassi PF, Pierconti F. Cytological feature of micropapillary and plasmacytoid variants of urothelial carcinoma. Diagn Cytopathol. 2020;48:111–7.

    Article  Google Scholar 

  27. Chan E, Balassanian R, Tabatabai ZL, Lou H, Vohra P. Improved diagnostic precision of urine cytology by implementation of the Paris system and the use of cell blocks. Cancer Cytopathol. 2018;126(9):809–16.

    Article  Google Scholar 

  28. Straccia P, Bizzarro T, Fadda G, Pierconti F. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris system for reporting urinary cytology. Cancer Cytopathol. 2016;124(7):519–23.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Momin T. Siddiqui .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Siddiqui, M.T. et al. (2022). High-Grade Urothelial Carcinoma (HGUC). In: Wojcik, E.M., Kurtycz, D.F., Rosenthal, D.L. (eds) The Paris System for Reporting Urinary Cytology. Springer, Cham. https://doi.org/10.1007/978-3-030-88686-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-88686-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-88685-1

  • Online ISBN: 978-3-030-88686-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Navigation